DHG Pharmaceutical JSC Statistics

Total Valuation

DHG Pharmaceutical JSC has a market cap or net worth of VND 14.40 trillion. The enterprise value is 12.71 trillion.

Market Cap	14.40T
Enterprise Value	12.71T

Important Dates

The next estimated earnings date is Monday, January 20, 2025.

Earnings Date	Jan 20, 2025
Ex-Dividend Date	Dec 24, 2024

Share Statistics

DHG Pharmaceutical JSC has 130.75 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	130.75M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+3.42%
Owned by Insiders (%)	8.18%
Owned by Institutions (%)	0.44%
Float	n/a

Valuation Ratios

The trailing PE ratio is 17.90 and the forward PE ratio is 14.32.

PE Ratio	17.90
Forward PE	14.32
PS Ratio	2.90
PB Ratio	3.26
P/TBV Ratio	3.40
P/FCF Ratio	17.08
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.07, with an EV/FCF ratio of 15.08.

EV / Earnings	15.81
EV / Sales	2.56
EV / EBITDA	13.07
EV / EBIT	14.67
EV / FCF	15.08

Financial Position

The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.26.

Current Ratio	2.72
Quick Ratio	1.90
Debt / Equity	0.26
Debt / EBITDA	1.19
Debt / FCF	1.37
Interest Coverage	35.66

Financial Efficiency

Return on equity (ROE) is 18.46% and return on invested capital (ROIC) is 9.92%.

Return on Equity (ROE)	18.46%
Return on Assets (ROA)	8.85%
Return on Capital (ROIC)	9.92%
Revenue Per Employee	1.77B
Profits Per Employee	287.58M
Employee Count	2,789
Asset Turnover	0.81
Inventory Turnover	1.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.21% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+10.21%
50-Day Moving Average	103,950.00
200-Day Moving Average	110,379.50
Relative Strength Index (RSI)	68.74
Average Volume (20 Days)	36,075

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DHG Pharmaceutical JSC had revenue of VND 4.96 trillion and earned 804.09 billion in profits. Earnings per share was 6,149.98.

Revenue	4.96T
Gross Profit	2.12T
Operating Income	866.67B
Pretax Income	928.91B
Net Income	804.09B
EBITDA	972.80B
EBIT	866.67B
Earnings Per Share (EPS)	6,149.98

Full Income Statement

Balance Sheet

The company has 2.84 trillion in cash and 1.16 trillion in debt, giving a net cash position of 1.68 trillion or 12,858.82 per share.

Cash & Cash Equivalents	2.84T
Total Debt	1.16T
Net Cash	1.68T
Net Cash Per Share	12,858.82
Equity (Book Value)	4.41T
Book Value Per Share	33,726.04
Working Capital	3.06T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.00 trillion and capital expenditures -159.56 billion, giving a free cash flow of 842.91 billion.

Operating Cash Flow	1.00T
Capital Expenditures	-159.56B
Free Cash Flow	842.91B
FCF Per Share	6,446.91

Full Cash Flow Statement

Margins

Gross margin is 42.82%, with operating and profit margins of 17.47% and 16.75%.

Gross Margin	42.82%
Operating Margin	17.47%
Pretax Margin	18.72%
Profit Margin	16.75%
EBITDA Margin	19.61%
EBIT Margin	17.47%
FCF Margin	16.99%

Dividends & Yields

This stock pays an annual dividend of 7,500.00, which amounts to a dividend yield of 6.81%.

Dividend Per Share	7,500.00
Dividend Yield	6.81%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	118.00%
Buyback Yield	n/a
Shareholder Yield	6.81%
Earnings Yield	5.59%
FCF Yield	5.86%

Dividend Details

Stock Splits

The last stock split was on May 26, 2017. It was a forward split with a ratio of 1.5.

Last Split Date	May 26, 2017
Split Type	Forward
Split Ratio	1.5

Scores

DHG Pharmaceutical JSC has an Altman Z-Score of 7.23.

Altman Z-Score	7.23
Piotroski F-Score	n/a